Expanded Program On Immunization

Expanded Program on Immunization

Background and Definition

Expanded Program on Immunization (EPI), established in 1987, aimes at guaranteeing the right of every child in Lebanon, regardless of social status or parent's education level, on immunization and protection from diseases that have available effective and safe vaccines. In order to ensure that, the Ministry of Public Health guarantees the provision of vaccines in 700 health care centers, public and social, in collaboration with the private sector and with the conitnuous awareness of care givers about the importance of immunization. The program provides further special attention to chidlren residing in remote and underprivileged areas through quality outreach activities.

EPI ِAims at:

Elevating routine vaccination coverage per district to above 95%.
Preserving Lebanon as polio-free, considering the continuous influx of Syrian refugees and in preparation to the eradication of polio in the region and worldwide.
Eradicating Measles and Rubella by the end of year 2018.

EPI Activities:

Continuous training and capacity building throughout the year for health care workers on routine vaccination management and implementation in all districs.
Continuous work to keep Lebanon certified polio-free
Implementation of the RED STRATEGY to reach every child, which includes:
1. Data on the immunization coverage for children under one year of age
2. Data on immunization coverage in Lebanon
3. Identification of the number of drop-outs and planning to ensure their vaccination per district accordingly
Celebrating World Immunization Week and planning awareness sessions over Lebanon about routine vaccination
Conducting National and Mop-Up Immunization campaigns annually, including vaccination against Measles, Rubella, and Mumps
Conducting regular visits by the self-assessment team to follow on the quality of vaccination delivery service
Continuous collaboration with UNICEFand WHO to follow-up on updates related to immunization worldwide and ensuring implementation in Lebanon considering national and international commitments
Continuous collaboration with the private sector (General Practictioners and Pediatricians) to ensure vaccination for all children in Lebanon, particularly during immunization campaigns and routine immunization.

...

119

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A12CX	PHOSPHATE DIPOTASSIQUE RENAUDIN	G	Phosphate dipotassique - 174.20mg/ml	174.20mg/ml	Injectable solution	1,189,301 L.L
B05AA01	UMAN ALBUMIN	BioHuman	Albumin human - 20g/100ml	10g/50ml	Injectable solution	3,598,810 L.L
B05XA03	SOLUFLEX SODIUM CHLORIDE 0.9% INJECTION USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	180,421 L.L
B05AA01	VIALEBEX	BioHuman	Albumin human - 200g/L	200g/L	Injectable solution	3,417,391 L.L
B05XA03	SOLUFLEX SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	218,344 L.L
L01FG01	BEVACIREL	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable solution	L.L
A03BB01	ANTIPAN	G	Hyoscine N butylbromide - 20mg/ml		Injectable solution	355,798 L.L
B05AA01	YDRALBUM 200G/L	BioHuman	Albumin human - 10g/50ml		Injectable solution	3,417,391 L.L
B05XA03	SOLUFLEX SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	203,405 L.L
J01XX08	ZYVOX IV	B	Linezolide - 600mg/300ml	600mg/300ml	Injectable solution	4,414,523 L.L
L01FG01	BEVACIREL	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable solution	L.L
A03BB01	ANTIPAN	G	Hyoscine N butylbromide - 20mg/ml		Injectable solution	2,557,140 L.L
B05AA06	GELASPAN	B	Gelatine, succinylated - 4%	4%	Injectable solution	9,107,572 L.L
B05XA03	SOLUFLEX SODIUM CHLORIDE 0.9% INJECTION, USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	179,272 L.L
H02AB02	DEXAMED	G	Dexamethasone - 8mg/2ml	8mg/2ml	Injectable solution	3,547,744 L.L
J01XX08	LINEDOR	G	Linezolide - 600mg/300ml	600mg/300ml	Injectable solution	2,045,328 L.L
L04AA52	KESIMPTA	BioTech	Ofatumumab - 20mg/0.4ml	20mg/0.4ml	Injectable solution	96,542,598 L.L
L04AB01	ETANERREL	BioTech	Etanercept - 25mg/0.5ml	25mg/0.5ml	Injectable solution	L.L
A03BB01	SCOBUREN	G	Butylscopolamine bromide - 20mg/ml	20mg/ml	Injectable solution	370,901 L.L
B05AA07	VOLUVEN	B	Starch poly(O-2-Hydroxyethyl) - 6%	6%	Injectable solution	987,724 L.L
B05XA03	0.45% SODIUM CHLORIDE INJECTION USP	G	Sodium chloride - 0.45%	0.45%	Injectable solution	160,885 L.L
H02AB02	DEXAMED	G	Dexamethasone - 8mg/2ml	8mg/2ml	Injectable solution	486,471 L.L
J01XX08	LINEZOLID ARROW	G	Linezolide - 600mg/300ml	2mg/ml	Injectable solution	13,282,147 L.L
L01BA04	PEMETREXED NEAPOLIS	G	Pemetrexed (disodium) - 100mg	100mg	Injectable solution	10,554,169 L.L
L04AB01	ALTEBREL	BioTech	Etanercept - 50mg/1ml	50mg/1ml	Injectable solution	14,833,767 L.L
A03BB01	SCOPINAL	G	Butylscopolamine bromide - 20mg/ml	20mg/ml	Injectable solution	178,731 L.L
B05BA01	AMINOVEN 10%	B	Glacial Acetic Acid 99% - 5.297g/l, L-Proline - 15.0g/l, L-Alanine - 15.0g/l, Glycine - 14.0g/l, L-Histidine - 3.00g/l, L-Arginine - 12.0g/l, L-Valine - 6.20g/l, L-Tryptophan - 2.00g/l, L-Threonine - 4.40g/l, L-Phenylalanine - 5.10g/l, L-Methionine - 4.30g/l, L-Lysine (monoacetate) - 6.60g/l, L-Leucine - 7.40g/l, L-Isoleucine - 5.00g/l		Injectable solution	951,440 L.L
B05XA03	0.45% SODIUM CHLORIDE INJECTION USP	G	Sodium chloride - 0.45%	0.45%	Injectable solution	176,974 L.L
H02AB02	DEXAMEDIS FORT	G	Dexamethasone Phosphate - 8mg/2ml	8mg/2ml	Injectable solution	43,003 L.L
J01XX08	ZERSA	G	Linezolide - 600mg/300ml	600mg/300ml	Injectable solution	3,303,165 L.L

...

119

...